Intro to Smart In Silico Tools to Aid in Translating In Vitro & In Vivo Studies
Safety issues account for about a quarter of the attrition in drug projects, and can…
Certara2020 年 10 月 5 日
Enabling Warp Speed Using the Hypervelocity Innovation Model: A Blue Print for Drug Development in Pandemics
Pharmaceutical R&D is organized around prioritized investments, delivering on assets with the greatest return of…
Certara2020 年 9 月 28 日
Payment Pressures in U.S. Specialty: Status quo and outlook for future financing
To allow for the optimal positioning of your product, portfolio, or company, it is critical…
Certara2020 年 9 月 15 日
New Pinnacle 21 Community Validation Engine: FDA (1907.2)
In August 2020, we released our new Pinnacle 21 validation engine “FDA (1907.2)” for preparing…
Certara2020 年 9 月 13 日
Exploring Common CDISC ADaM Dataset Conformance Findings
What you need to know when validating your CDISC ADAM datasets During the regulatory review…
Certara2020 年 9 月 3 日
Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
As of 2020 年 7 月 28 日, 1840 clinical trials were registered globally, with 1001 clinical trials…
Certara2020 年 8 月 22 日
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…
Certara2020 年 8 月 22 日
